Sun Pharmaceutical Industries Ltd

Common Name
Sun Pharmaceutical Industries
Country
India
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
43,000
Ticker
SUNPHARMA
Exchange
NATIONAL STOCK EXCHANGE OF INDIA
Description
Sun Pharmaceutical Industries Ltd. is a major player in the global pharmaceutical industry, specializing in the manufacturing and marketing of a broad array of pharmaceutical formulations and active p...
GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Sun Pharmaceutical Industries's GHG Emissions Data Preview

In 2025, Sun Pharmaceutical Industries completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources).

However, Sun Pharmaceutical Industries has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2025202420232022 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
0000000
Download Data

Verified Sources Behind Sun Pharmaceutical Industries’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Sun Pharmaceutical Industries’s data sources below and access millions more through our Disclosure Search.

a. Sun Pharmaceutical Industries's Annual Report 2025
a. Sun Pharmaceutical Industries's Annual Report 2025
b. Sun Pharmaceutical Industries's Sustainability Report 2023
b. Sun Pharmaceutical Industries's Sustainability Report 2023
c. Sun Pharmaceutical Industries's Sustainability Report 2022
c. Sun Pharmaceutical Industries's Sustainability Report 2022

Insights into Sun Pharmaceutical Industries's Operational Emissions

In 2025, the total operational greenhouse gas (GHG) emissions of Sun Pharmaceutical Industries amounted to 156,242 metric tons of CO2 equivalent. This figure reflects direct emissions from owned or controlled sources (Scope 1). a

Compared to 2024, the total operational greenhouse gas (GHG) emissions of Sun Pharmaceutical Industries increased by 40.54%, suggesting that the company faced challenges in reducing its emissions from its core operations. a

Sun Pharmaceutical Industries's Scope 1 Emissions Over Time

2019202020212022202320242025040 k80 k120 k160 ktCO2e+22%-19%-1%-12%+65%+41%
  • Total Scope 1
  • Year-over-Year Change

What are Sun Pharmaceutical Industries's Scope 1 emissions?

In 2025, the total Scope 1 emissions of Sun Pharmaceutical Industries were 156,242 metric tons of CO₂ equivalent (tCO₂e). a

Has Sun Pharmaceutical Industries reduced its Scope 1 emissions over time?

Since 2019, Sun Pharmaceutical Industries's Scope 1 emissions have increased by 101.3%, reflecting a rising long-term trend in Scope 1 emissions over time. a c

Compared to the previous year (2024), Sun Pharmaceutical Industries's Scope 1 emissions increased by 40.54%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a

Insights into Sun Pharmaceutical Industries’s GHG Emissions Intensity Compared to Industry Peers

In 2025, Sun Pharmaceutical Industries reported Scope 1 greenhouse gas (GHG) emissions of 156,242 tCO₂e and total revenues of USD 6,091 millions. This translates into an emissions intensity of 25.65 tCO₂e per millions USD. a

Sun Pharmaceutical Industries's Scope 1 Emissions Intensity Compared to Peers

1001,00020,000200,0002,000,000Scope 1 Emissions (tCO2e)502001,0002,00010,000Revenues (Millions of USD)OJDivi's LaboratoriesYear: 2025Scope 1: 339,941 tCO2eRevenue: $M 1,091Scope 1 Intensity: 311.47 tCO2e/$MAurobindo PharmaYear: 2025Scope 1: 750,616 tCO2eRevenue: $M 3,672Scope 1 Intensity: 204.39 tCO2e/$MMankind PharmaYear: 2025Scope 1: 6,538 tCO2eRevenue: $M 1,429Scope 1 Intensity: 4.58 tCO2e/$MZydus LifesciencesYear: 2023Scope 1: 44,792 tCO2eRevenue: $M 2,056Scope 1 Intensity: 21.79 tCO2e/$MAarti PharmalabsYear: 2024Scope 1: 88,101 tCO2eRevenue: $M 218Scope 1 Intensity: 404.68 tCO2e/$MAlembic PharmaceuticalsYear: 2025Scope 1: 80,278 tCO2eRevenue: $M 765Scope 1 Intensity: 104.88 tCO2e/$MAjanta PharmaYear: 2025Scope 1: 6,392 tCO2eRevenue: $M 537Scope 1 Intensity: 11.90 tCO2e/$MAbbott IndiaYear: 2025Scope 1: 232 tCO2eRevenue: $M 750Scope 1 Intensity: 0.31 tCO2e/$MCiplaYear: 2025Scope 1: 38,283 tCO2eRevenue: $M 3,177Scope 1 Intensity: 12.05 tCO2e/$MJB PharmaYear: 2025Scope 1: 5,652 tCO2eRevenue: $M 452Scope 1 Intensity: 12.50 tCO2e/$MNatco PharmaYear: 2025Scope 1: 28,495 tCO2eRevenue: $M 518Scope 1 Intensity: 54.96 tCO2e/$MGlenmark PharmaceuticalsYear: 2025Scope 1: 34,547 tCO2eRevenue: $M 1,539Scope 1 Intensity: 22.45 tCO2e/$MTorrent PharmaceuticalsYear: 2025Scope 1: 8,937 tCO2eRevenue: $M 1,325Scope 1 Intensity: 6.75 tCO2e/$MStrides Pharma ScienceYear: 2023Scope 1: 6,168 tCO2eRevenue: $M 439Scope 1 Intensity: 14.04 tCO2e/$MCohance LifesciencesYear: 2025Scope 1: 31,818 tCO2eRevenue: $M 140Scope 1 Intensity: 227.00 tCO2e/$MOOOrchid PharmaYear: 2025Scope 1: 74,800 tCO2eRevenue: $M 108Scope 1 Intensity: 693.22 tCO2e/$MAlkem LaboratoriesYear: 2025Scope 1: 33,018 tCO2eRevenue: $M 1,499Scope 1 Intensity: 22.03 tCO2e/$MGland PharmaYear: 2025Scope 1: 13,920 tCO2eRevenue: $M 654Scope 1 Intensity: 21.30 tCO2e/$MLupinYear: 2025Scope 1: 82,174 tCO2eRevenue: $M 2,597Scope 1 Intensity: 31.64 tCO2e/$MPiramal PharmaYear: 2025Scope 1: 61,351 tCO2eRevenue: $M 1,061Scope 1 Intensity: 57.85 tCO2e/$MIPCA LaboratoriesYear: 2025Scope 1: 169,992 tCO2eRevenue: $M 1,036Scope 1 Intensity: 164.03 tCO2e/$MJJJubilant PharmovaYear: 2025Scope 1: 10,084 tCO2eRevenue: $M 842Scope 1 Intensity: 11.98 tCO2e/$MDr Reddy's LaboratoriesYear: 2025Scope 1: 142,772 tCO2eRevenue: $M 3,810Scope 1 Intensity: 37.47 tCO2e/$MGranules IndiaYear: 2024Scope 1: 58,254 tCO2eRevenue: $M 538Scope 1 Intensity: 108.19 tCO2e/$MSun Pharmaceutical IndustriesYear: 2025Scope 1: 156,242 tCO2eRevenue: $M 6,091Scope 1 Intensity: 25.65 tCO2e/$M

How does Sun Pharmaceutical Industries's GHG emissions intensity compare to its peers?

In 2025, Sun Pharmaceutical Industries reported a Scope 1 emissions intensity of 25.65 tCO₂e per millions USD. Compared to the peer group median of 27.05 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Sun Pharmaceutical Industries rank on GHG emissions intensity within its industry?

In 2025, Sun Pharmaceutical Industries ranked 13 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

Sun Pharmaceutical Industries is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a

Want Full Access to Sun Pharmaceutical Industries's GHG Emissions Dataset?
Sign Up

Explore Peer Companies

Granules India Ltd

Healthcare
Drug Manufacturers - Specialty & Generic
India

Dr Reddy's Laboratories Ltd

Healthcare
Drug Manufacturers - Specialty & Generic
India

Jubilant Pharmova Ltd

Healthcare
Drug Manufacturers - Specialty & Generic
India

IPCA Laboratories Ltd

Healthcare
Drug Manufacturers - Specialty & Generic
India

Piramal Pharma Ltd

Healthcare
Drug Manufacturers - Specialty & Generic
India

Lupin Ltd

Healthcare
Drug Manufacturers - Specialty & Generic
India